Subscribe
shutterstock_1933658318_martinbertrand_fr
martinbertrand.fr / Shutterstock.com
15 July 2022Big Pharma

Bad news for Italy’s EMA relocation challenge

EU’s top court denies bid that Amsterdam decision was a “misuse of powers”

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
No coronavirus-related drug shortages yet, says EMA
11 March 2020   The European Medicines Agency has said that no drug shortages or supply disruptions due to the coronavirus outbreak have been reported, but that a steering group has convened to address the epidemic’s impact on the supply of medicines in the EU.
Big Pharma
Emer Cooke becomes first woman to lead EMA
18 November 2020   The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.
Biotechnology
EMA backs switch to biosimilars
22 September 2022   Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Big Pharma
Emer Cooke becomes first woman to lead EMA
18 November 2020   The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.
Biotechnology
EMA backs switch to biosimilars
22 September 2022   Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.
Big Pharma
No coronavirus-related drug shortages yet, says EMA
11 March 2020   The European Medicines Agency has said that no drug shortages or supply disruptions due to the coronavirus outbreak have been reported, but that a steering group has convened to address the epidemic’s impact on the supply of medicines in the EU.

More on this story

Big Pharma
Emer Cooke becomes first woman to lead EMA
18 November 2020   The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role.
Biotechnology
EMA backs switch to biosimilars
22 September 2022   Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.
Big Pharma
No coronavirus-related drug shortages yet, says EMA
11 March 2020   The European Medicines Agency has said that no drug shortages or supply disruptions due to the coronavirus outbreak have been reported, but that a steering group has convened to address the epidemic’s impact on the supply of medicines in the EU.

More features

Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner
Apple wins just $250 in Masimo smartwatch clash
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
Big Pharma counsel embrace AI but data and legal risks loom